A randomized phase III study of tumor volume directed pelvic plus or minus para-aortic irradiation followed by cisplatin and doxorubicin or cisplatin, doxorubicin and paclitaxel for advanced endometrial carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Doxorubicin; Paclitaxel
- Indications Endometrial cancer
- Focus Therapeutic Use
- 19 May 2015 Biomarkers information updated
- 30 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 30 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.